Adverse events of statin–fenofibric acid versus statin monotherapy: a meta-analysis of randomized controlled trials

By Geng Qiang   Ren Jingyi   Chen Hong   Lee Chongyou   Liang Wenqing  

Current Medical Research and Opinion, Vol. 29, Iss. 3, 2013-03 ,pp. : 181-188

Informa Healthcare

Access to resources Recommend Favorite

Adverse event monitoring in oncology clinical trials

By Russell Jeffery S   Colevas A Dimitrios  

Clinical Investigation, Vol. 3, Iss. 12, 2013-12 ,pp. : 1157-1165

Future Science

Access to resources Recommend Favorite

The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis

By Ramey Dena R.   Watson Douglas J.   Yu Chang   Bolognese James A.   Curtis Sean P.   Reicin Alise S.  

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 715-722

Informa Healthcare

Access to resources Recommend Favorite

Do we Need a New Procedure for the Assessment of Adverse Events in Anti-migraine Clinical Trials?

By  

Recent Patents on CNS Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 41-47

Bentham Science Publishers

Access to resources Recommend Favorite

The Detection of Adverse Events in Randomized Clinical Trials: Can we Really Say New Medicines are Safe?

By  

Current Drug Safety, Vol. 8, Iss. 2, 2013-01 ,pp. : 104-113

Bentham Science Publishers

Access to resources Recommend Favorite